dolasetron Anzemet
Selected indexed studies
- Dolasetron. (, 2006) [PMID:33630484]
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (Cochrane Database Syst Rev, 2020) [PMID:33075160]
- Palonosetron. (Drugs, 2004) [PMID:15139789]
_Worker-drafted node — pending editorial review._
Connections
dolasetron Anzemet is a side effect of
Sources
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (2020) pubmed
- Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. (2021) pubmed
- Dolasetron. (2006) pubmed
- Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. (1997) pubmed
- Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review. (2007) pubmed
- Palonosetron. (2004) pubmed
- Comparison of the pharmacokinetics of dolasetron and its major active metabolite, reduced dolasetron, in dog. (1996) pubmed
- New antiemetic drugs. (2006) pubmed
- Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjects. (1995) pubmed
- Pharmacokinetics of single intravenous and oral doses of dolasetron mesylate in healthy elderly volunteers. (1996) pubmed